Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
11.64
-0.20 (-1.69%)
At close: Jun 27, 2025, 4:00 PM
11.42
-0.22 (-1.89%)
After-hours: Jun 27, 2025, 5:25 PM EDT
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $887.38 million as of June 27, 2025. Its market cap has decreased by -6.79% in one year.
Market Cap
887.38M
Enterprise Value
364.33M
1-Year Change
-6.79%
Ranking
Category
Stock Price
$11.64
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $887.38M, an increase of 26.03%. That is a compound annual growth rate of 4.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 885.86M | -33.62% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | 1.28B | 81.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 714.27B |
| Johnson & Johnson | 366.95B |
| AbbVie | 330.35B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 275.16B |
| Abbott Laboratories | 232.49B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |